INFECTION COMPLICATIONS AFTER COLON-PROCTOLOGIC SURGERIES: EPIDEMIOLOGY, PATHOGENESIS AND PREVENTION
https://doi.org/10.21292/2078-5658-2015-12-6-86-93
Abstract
The review presents some data that reflect the incidence frequency, pathogenesis and approaches to the prevention of infectious complications after coloproctological surgery. They show no uniform recommendations for prevention thereof using the techniques and technologies available with the emergency care specialists. The effectiveness of various pro- and prebiotics, fecal microbiota transplantation are most extensively studied. Also the role of changes in intestinal canal biocenosis and endoluminal translocation in the pathogenesis of systemic infection and other infectious complications is demonstrated.
About the Authors
I. V. Shlyk
Pavlov First Saint Petersburg State Medical University, Research Institute of Pulmonology,
St. Petersburg
Russian Federation
Russian Federation
A. A. Zakharenko
Pavlov First Saint Petersburg State Medical University, Research Institute of Pulmonology,
St. Petersburg
Russian Federation
Russian Federation
V. A. Panafidina
Pavlov First Saint Petersburg State Medical University, Research Institute of Pulmonology,
St. Petersburg
Russian Federation
Russian Federation
O. N. Ten
Pavlov First Saint Petersburg State Medical University, Research Institute of Pulmonology,
St. Petersburg
Russian Federation
Russian Federation
References
1. Nekhaev I.V. Sepsis v torakoabdominal'noy onkokhirurgii. [Sepsis in thoracic abdomen oncosurgery]. Moscow, ABV-press Publ., 2011, 208 p.
2. Petukhova I.N. Antibiotic prevention of post-surgery wound infections. Soprovoditel'naya Terapiya v Onkologii, 2005, no. 1, pp. 2-10. (In Russ.)
3. Plotkin L.L., Zlakazov M.P., Krasnopeev V.А. Clinical impact of bacteremia in patients after colon proctologic surgery. Vestnik Anasteziol. i Reanimatol., 2015, vol. 12, no. 1, pp. 40-45. (In Russ.)
4. Zlokachestvennye novoobrazovaniya v Rossii i stranakh SNG v 2012 g. [Malicious tumors in Russia and CIS countries in 2012]. Ed. by M.I. Davydov, E.M. Aksel, Moscow, Izdatelskaya Gruppa RONTS Publ., 2014, 226 p.
5. Blumetti J. et al. Surgical site infections after colorectal surgery: do risk factors vary depending on the type of infection considered? Surgery, 2007, vol. 142, no. 5, pp. 704-711.
6. Chin K.F. et al. Bacterial translocation may influence the long-term survival in colorectal cancer patients. Diseases of the colon & rectum, 2007, vol. 50, no. 3, pp. 323-330.
7. Chun Y.J. et al. Prospective assessment of risk of bacteremia following colorectal stent placement. Digestive diseases and sciences, 2012, vol. 57, no. 4, pp. 1045-1049.
8. Cohen S.H. et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control, 2010, vol. 31, no. 5, pp. 431-455.
9. Corredoira-Sánchez J. et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin.Infect. Dis., 2012, vol. 55, no. 4, pp. 491-496.
10. Damle R.N. et al. Clostridium difficile infection after colorectal surgery: a rare but costly complication. J. Gastrointestinal Surgery, 2014, vol. 18, no. 10, pp. 1804-1811.
11. Degrate L. et al. Right colon, left colon, and rectal surgeries are not similar for surgical site infection development. Analysis of 277 elective and urgent colorectal resections. Int. J. Colorectal Dis., 2011, vol. 26, no. 1, pp. 61-69.
12. Deitch E.A. Gut-origin sepsis: evolution of a concept. Surgeon, 2012, vol. 10, no. 6, pp. 350-356.
13. Evans C., Dalgleish A.G., Kumar D. Review article: immune suppression and colorectal cancer. Alimentary pharmacology & therapeutics, 2006, vol. 24, no. 8, pp. 1163-1177.
14. Fry D.E. The prevention of surgical site infection in elective colon surgery. Scientifica. 2013, http://dx.doi.org/10.1155/2013/896297.
15. Gens K.D., Elshaboury R.H., Holt J.S. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection. Journal of pharmacy practice, 2013, vol. 26, no. 5, pp. 498-505.
16. Goedert J.J. et al. Fecal microbiota characteristics of patients with colorectal adenoma detected by screening: a population-based study. EBioMedicine. 2015, http://dx.doi.org/10.1016/j.ebiom.2015.04.010.
17. Grosso G. et al. Major postoperative complications and survival for colon cancer elderly patients. BMC surgery, 2012, vol. 12, suppl. 1, doi: 10.1186/1471-2482-12-S1-S20.
18. Hatch Q. et al. Can sepsis predict deep venous thrombosis in colorectal surgery? Am. J. Surgery, 2015, doi:10.1016/j.amjsurg.2015.06.016.
19. Hermans E. et al. Outcome of colonic surgery in elderly patients with colon cancer. J. Oncology, 2010, doi:10.1155/2010/865908.
20. Ishikawa K. et al. Incisional surgical site infection after elective open surgery for colorectal cancer. International journal of surgical oncology, 2014, vol. 2014, http://dx.doi.org/10.1155/2014/419712.
21. Kawecki D. et al. Etiological agents of bacteremia in the early period after liver transplantation. Transplantation proceedings, 2007, vol. 39, no. 9, pp. 2816-2821.
22. Konishi T. et al. Elective colon and rectal surgery differ in risk factors for wound infection: results of prospective surveillance. Annals of surgery, 2006, vol. 244, no. 5, pp. 758-763.
23. Krapohl G.L. et al. Bowel preparation for colectomy and risk of Clostridium difficile infection. Diseases of the colon & rectum, 2011, vol. 54, no. 7, pp. 810-817.
24. Law W.L. et al. Impact of laparoscopic resection for colorectal cancer on operative outcomes and survival. Ann. Surgery, 2007, vol. 245, no. 1, pp. 1-7.
25. Lemmens V.E.P.P., Janssen-Heijnen, M.L.G., Houterman S. et al. Which comorbid conditions predict complications after surgery for colorectal cancer? World J. Surgery, 2007, vol. 31, no. 1, pp. 192-199.
26. Lesperance K. et al. The morbidity of Clostridium difficile infection after elective colonic resection–results from a national population database. Am. J. Surgery, 2011, vol. 201, no. 2, pp. 141-148.
27. Liu Z. et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post‐operative infectious complications in colorectal cancer surgery-a double‐blind study. Alimentary pharmacology & therapeutics, 2011, vol. 33, no. 1, pp. 50-63.
28. Liu Z.H. et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. Am. Journal Clinical Nutrition, 2013, vol. 97, no. 1, pp. 117-126.
29. Longo W.E. et al. Risk factors for morbidity and mortality after colectomy for colon cancer. Diseases of the colon & rectum, 2000, vol. 43, no. 1, pp. 83-91.
30. MacFie J. et al. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut., 1999, vol. 45, no. 2, pp. 223-228.
31. McGillicuddy E.A. et al. Factors predicting morbidity and mortality in emergency colorectal procedures in elderly patients. Archives of Surgery, 2009, vol. 144, no. 12, pp. 1157-1162.
32. Nakamura T. et al. Risk factors for wound infection after surgery for colorectal cancer. World journal of surgery, 2008, vol. 32, no. 6, pp. 1138-1141.
33. Narayanan V., Peppelenbosch M.P., Konstantinov S.R. Human fecal microbiome-based biomarkers for colorectal cancer. Cancer Prevention Research, 2014, vol. 7, no. 11, pp. 1108-1111.
34. Nistal E. et al. Factors determining colorectal cancer: the role of the intestinal microbiota. Frontiers in Oncology, 2015, vol. 5, doi: 10.3389/fonc.2015.00220.
35. O’Boyle C.J. et al. Microbiology of bacterial translocation in humans. Gut., 1998, vol. 42, no. 1, pp. 29-35.
36. O’horo J.C. et al. Treatment of recurrent Clostridium difficile infection: a systematic review. Infection, 2014, vol. 42, no. 1, pp. 43-59.
37. Ohigashi S. et al. Significant changes in the intestinal environment after surgery in patients with colorectal cancer. Journal of Gastrointestinal Surgery, 2013, vol. 17, no. 9, pp. 1657-1664.
38. Osada T. et al. Thoracic empyema associated with recurrent colon cancer. Diseases of the colon & rectum, 2001, vol. 44, no. 2, pp. 291-294.
39. Paun B.C. et al. Postoperative complications following surgery for rectal cancer. Annals of surgery, 2010, vol. 251, no. 5, pp. 807-818.
40. Raskin E.R., Madoff R.D. Complications of rectal cancer surgery. Modern Management of Cancer of the Rectum. 2015, pp. 447-459.
41. Reddy B.S. et al. Surgical manipulation of the large intestine increases bacterial translocation in patients undergoing elective colorectal surgery. Colorectal Disease, 2006, vol. 8, no. 7, pp. 596-600.
42. Rodriguez S. et al. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C. difficile infection. Clin. Gastroenterology and Hepatology, 2014, vol. 12, no. 11, pp. 1856-1861.
43. Schietroma M. et al. Laparoscopic versus open colorectal surgery for colon cancer: the effect of surgical trauma on the bacterial translocation. A prospective randomized study. Am.J. Surgery, 2015, doi: 10.1016/j.amjsurg.2014.09.031.
44. Serra-Aracil X. et al. Surgical site infection in elective operations for colorectal cancer after the application of preventive measures. Arch. Surgery, 2011, vol. 146, no. 5, pp. 606-612.
45. Klemens S. et al. Using machine-learned Bayesian belief networks to predict perioperative risk of Clostridium difficile infection following colon surgery. Interact. J. Med. Research, 2012, vol. 1, no. 2, pp. e6. doi: 10.2196/ijmr.2131.
46. Surawicz C.M. et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am. J. Gastroenterology, 2013, vol. 108, no. 4, pp. 478-498.
47. Tjandra J.J. et al. Fatal Clostridium difficile infection of the small bowel after complex colorectal surgery. ANZ J. Surgery, 2001, vol. 71, no. 8, pp. 500-503.
48. Tsujimoto H. et al. Postoperative infections are associated with adverse outcome after resection with curative intent for colorectal cancer. Oncology letters, 2010, vol. 1, no. 1, pp. 119-125.
49. Weinstein M.P. et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Inf. Dis., 1997, vol. 24, no. 4, pp. 584-602.
50. Yeom C.H. et al. Risk factors for the development of Clostridium difficile-associated colitis after colorectal cancer surgery. J. Korean Society Coloproctology, 2010, vol. 26, no. 5. pp. 329-333.
Review
For citations:
Shlyk I.V., Zakharenko A.A., Panafidina V.A., Ten O.N. INFECTION COMPLICATIONS AFTER COLON-PROCTOLOGIC SURGERIES: EPIDEMIOLOGY, PATHOGENESIS AND PREVENTION. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2015;12(6):86-93. (In Russ.) https://doi.org/10.21292/2078-5658-2015-12-6-86-93
Email this article 